# Novonesis financial performance and stock growth

> Live situation record from CLSTR: https://clstr.news/situations/novonesis-financial-performance-and-stock-growth
> Updated: 2026-08-19T18:34:33.000Z. Sources: 2. Developments: 2.

Novonesis reported strong second-quarter financial results, leading to its largest single-day stock gain in over a decade. The biotechnology group achieved a profit of 179.4 million euros and revenue of 1,116.2 million euros, exceeding analyst expectations.

Driven by demand in the food and beverage sector for healthier solutions, the company raised its organic revenue growth guidance for the remainder of the year to 7-8 percent, up from the previous estimate of 5-7 percent. Following these results, the stock topped the Danish C25 index, rising by more than ten percent.

## Timeline

### 2026-08-19: Novonesis stock sees largest gain in a decade following strong earnings

Novonesis shares surged over 10% following strong Q2 earnings that exceeded expectations and led the company to raise its annual organic revenue growth guidance.

2 sources. https://clstr.news/cluster/novonesis-stock-sees-largest-gain-in-a-decade-following-strong-earnings

### 2026-07-28: Novo Nordisk stock climbs as investors await August earnings and dividend

Novo Nordisk shares rose to $50.96 as analysts await August earnings, projected EPS $0.82, and an upcoming dividend, while recent revenue fell 4% but demand for Wegovy remains strong.

2 sources. https://clstr.news/cluster/novo-nordisk-stock-climbs-as-investors-await-august-earnings-and-dividend

---
Cite as: Novonesis financial performance and stock growth. CLSTR, https://clstr.news/situations/novonesis-financial-performance-and-stock-growth